RCUS
HealthcareArcus Biosciences, Inc.
$21.83-0.87 (-3.83%)
Prev Close
$22.70
Open
$22.71
High
$23.06
Low
$21.69
Volume
772.7K
Market Cap
$2.35B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Arcus Biosciences, Inc. (RCUS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 12 insider sales totaling $5.99M. The most recent insider transaction was by Jaen Juan C. (President), who sold $681.3K worth of shares on Jan 5, 2026. Arcus Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.35B.
Buys (12M)
0
$0.00
Sells (12M)
12
$5.99M
Net Activity
Net Seller
$5.99M
Active Insiders
5
last 12 mo
RCUS Price Chart
RCUS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026↗ | Jaen Juan C. | President | Sell | 31,823 | $21.41 | $681.3K | 0 |
| Dec 31, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 6,552 | $23.38 | $153.2K | 0 |
| Dec 16, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 8,832 | $22.13 | $195.4K | 0 |
| Dec 16, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 12,662 | $22.01 | $278.7K | 0 |
| Dec 16, 2025↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,208 | $22.01 | $466.9K | 0 |
| Dec 16, 2025↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 54,691 | $22.01 | $1.20M | 0 |
| Dec 4, 2025↗ | Jaen Juan C. | President | Sell | 82,997 | $24.71 | $2.05M | 0 |
| Nov 26, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,900 | $26.00 | $49.4K | 0 |
| Oct 28, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 5,000 | $20.00 | $100.0K | 0 |
| Oct 6, 2025↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 50,292 | $14.92 | $750.4K | 0 |
| Sep 29, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 2,831 | $13.00 | $36.8K | 0 |
| Sep 5, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,579 | $11.88 | $18.8K | 0 |
| Feb 27, 2025↗ | KANEKO YASUNORI | Director | Buy | 20,000 | $10.06 | $201.2K | 0 |
| Feb 27, 2025↗ | ROSEN TERRY J | Chief Executive Officer | Buy | 19,800 | $10.18 | $201.5K | 0 |
| Feb 20, 2025↗ | GILEAD SCIENCES, INC. | 10% Owner | Buy | 1,363,636 | $11.00 | $15.00M | 31,424,800 |
| Jan 3, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 3,594 | $15.00 | $53.9K | 60,138 |
| Dec 4, 2024↗ | Azoy Alexander | Chief Accounting Officer | Sell | 201 | $15.32 | $3.1K | 19,070 |
| Aug 15, 2024↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,357 | $14.97 | $20.3K | 19,070 |
| Mar 29, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 11,551 | $17.55 | $202.7K | 215,253 |
| Mar 20, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 13,449 | $17.92 | $240.9K | 228,100 |
| Feb 28, 2024↗ | Jaen Juan C. | President | Sell | 27,032 | $20.09 | $543.2K | 1,211,360 |
| Feb 28, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 58,625 | $20.09 | $1.18M | 274,323 |
| Jan 4, 2024↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 2,004 | $20.00 | $40.1K | 51,831 |
| Jan 4, 2024↗ | Jaen Juan C. | President | Sell | 6,975 | $20.09 | $140.1K | 1,215,260 |
| Dec 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,521 | $17.76 | $382.2K | 258,878 |
| Dec 5, 2023↗ | Azoy Alexander | Chief Accounting Officer | Sell | 282 | $14.95 | $4.2K | 11,596 |
| Sep 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,369 | $19.99 | $427.2K | 302,691 |
| Jul 31, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 45,000 | $20.25 | $911.3K | 336,566 |
| Jul 5, 2023↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,018 | $20.41 | $20.8K | 11,596 |
| Jun 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,437 | $19.12 | $237.8K | 381,566 |
| Jun 16, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,563 | $19.35 | $243.1K | 394,003 |
| Jun 9, 2023↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 4,049 | $20.04 | $81.1K | 59,392 |
| Mar 20, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 8,729 | $16.81 | $146.7K | 406,217 |
| Jan 30, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 1,900 | $23.53 | $44.7K | 416,546 |
| Dec 16, 2022↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 2,453 | $30.75 | $75.4K | 11,953 |
| Dec 16, 2022↗ | Jaen Juan C. | President | Sell | 4,436 | $30.75 | $136.4K | 218,959 |
| Dec 16, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 16,482 | $30.75 | $506.8K | 150,212 |
| Dec 16, 2022↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 13,043 | $30.75 | $401.1K | 244,233 |
| Dec 16, 2022↗ | Tang Carolyn C. | General Counsel | Sell | 2,523 | $30.75 | $77.6K | 28,982 |
| Sep 20, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,677 | $26.28 | $333.2K | 130,942 |
| Jun 21, 2022↗ | Jaen Juan C. | President | Sell | 4,870 | $21.45 | $104.5K | 212,574 |
| Jun 21, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,695 | $21.45 | $272.3K | 125,233 |
| Jun 21, 2022↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 8,854 | $21.45 | $189.9K | 232,329 |
| Jun 21, 2022↗ | Tang Carolyn C. | General Counsel | Sell | 2,922 | $21.45 | $62.7K | 25,431 |
| Mar 18, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 9,617 | $31.62 | $304.1K | 105,978 |
| Dec 22, 2021↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 34,822 | $41.48 | $1.44M | 114,318 |
| Dec 20, 2021↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 1,106 | $40.12 | $44.4K | 7,771 |
| Dec 20, 2021↗ | Jaen Juan C. | President | Sell | 1,973 | $40.12 | $79.2K | 202,498 |
| Dec 20, 2021↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,678 | $40.12 | $508.7K | 134,031 |
| Dec 20, 2021↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 5,242 | $40.12 | $210.3K | 215,132 |
Showing 1–50 of 63
1 / 2
RCUS Insider Buying Activity
The following table shows recent insider purchases of Arcus Biosciences, Inc. (RCUS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 27, 2025↗ | KANEKO YASUNORI | Director | Buy | 20,000 | $10.06 | $201.2K | 0 |
| Feb 27, 2025↗ | ROSEN TERRY J | Chief Executive Officer | Buy | 19,800 | $10.18 | $201.5K | 0 |
| Feb 20, 2025↗ | GILEAD SCIENCES, INC. | 10% Owner | Buy | 1,363,636 | $11.00 | $15.00M | 31,424,800 |
RCUS Insider Selling Activity
The following table shows recent insider sales of Arcus Biosciences, Inc. (RCUS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026↗ | Jaen Juan C. | President | Sell | 31,823 | $21.41 | $681.3K | 0 |
| Dec 31, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 6,552 | $23.38 | $153.2K | 0 |
| Dec 16, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 8,832 | $22.13 | $195.4K | 0 |
| Dec 16, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 12,662 | $22.01 | $278.7K | 0 |
| Dec 16, 2025↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,208 | $22.01 | $466.9K | 0 |
| Dec 16, 2025↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 54,691 | $22.01 | $1.20M | 0 |
| Dec 4, 2025↗ | Jaen Juan C. | President | Sell | 82,997 | $24.71 | $2.05M | 0 |
| Nov 26, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,900 | $26.00 | $49.4K | 0 |
| Oct 28, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 5,000 | $20.00 | $100.0K | 0 |
| Oct 6, 2025↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 50,292 | $14.92 | $750.4K | 0 |
| Sep 29, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 2,831 | $13.00 | $36.8K | 0 |
| Sep 5, 2025↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,579 | $11.88 | $18.8K | 0 |
| Jan 3, 2025↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 3,594 | $15.00 | $53.9K | 60,138 |
| Dec 4, 2024↗ | Azoy Alexander | Chief Accounting Officer | Sell | 201 | $15.32 | $3.1K | 19,070 |
| Aug 15, 2024↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,357 | $14.97 | $20.3K | 19,070 |
| Mar 29, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 11,551 | $17.55 | $202.7K | 215,253 |
| Mar 20, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 13,449 | $17.92 | $240.9K | 228,100 |
| Feb 28, 2024↗ | Jaen Juan C. | President | Sell | 27,032 | $20.09 | $543.2K | 1,211,360 |
| Feb 28, 2024↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 58,625 | $20.09 | $1.18M | 274,323 |
| Jan 4, 2024↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 2,004 | $20.00 | $40.1K | 51,831 |
| Jan 4, 2024↗ | Jaen Juan C. | President | Sell | 6,975 | $20.09 | $140.1K | 1,215,260 |
| Dec 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,521 | $17.76 | $382.2K | 258,878 |
| Dec 5, 2023↗ | Azoy Alexander | Chief Accounting Officer | Sell | 282 | $14.95 | $4.2K | 11,596 |
| Sep 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 21,369 | $19.99 | $427.2K | 302,691 |
| Jul 31, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 45,000 | $20.25 | $911.3K | 336,566 |
| Jul 5, 2023↗ | Azoy Alexander | Chief Accounting Officer | Sell | 1,018 | $20.41 | $20.8K | 11,596 |
| Jun 26, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,437 | $19.12 | $237.8K | 381,566 |
| Jun 16, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,563 | $19.35 | $243.1K | 394,003 |
| Jun 9, 2023↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 4,049 | $20.04 | $81.1K | 59,392 |
| Mar 20, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 8,729 | $16.81 | $146.7K | 406,217 |
| Jan 30, 2023↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 1,900 | $23.53 | $44.7K | 416,546 |
| Dec 16, 2022↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 2,453 | $30.75 | $75.4K | 11,953 |
| Dec 16, 2022↗ | Jaen Juan C. | President | Sell | 4,436 | $30.75 | $136.4K | 218,959 |
| Dec 16, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 16,482 | $30.75 | $506.8K | 150,212 |
| Dec 16, 2022↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 13,043 | $30.75 | $401.1K | 244,233 |
| Dec 16, 2022↗ | Tang Carolyn C. | General Counsel | Sell | 2,523 | $30.75 | $77.6K | 28,982 |
| Sep 20, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,677 | $26.28 | $333.2K | 130,942 |
| Jun 21, 2022↗ | Jaen Juan C. | President | Sell | 4,870 | $21.45 | $104.5K | 212,574 |
| Jun 21, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,695 | $21.45 | $272.3K | 125,233 |
| Jun 21, 2022↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 8,854 | $21.45 | $189.9K | 232,329 |
| Jun 21, 2022↗ | Tang Carolyn C. | General Counsel | Sell | 2,922 | $21.45 | $62.7K | 25,431 |
| Mar 18, 2022↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 9,617 | $31.62 | $304.1K | 105,978 |
| Dec 22, 2021↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 34,822 | $41.48 | $1.44M | 114,318 |
| Dec 20, 2021↗ | Goeltz II Robert C. | Chief Financial Officer | Sell | 1,106 | $40.12 | $44.4K | 7,771 |
| Dec 20, 2021↗ | Jaen Juan C. | President | Sell | 1,973 | $40.12 | $79.2K | 202,498 |
| Dec 20, 2021↗ | Jarrett Jennifer | Chief Operating Officer | Sell | 12,678 | $40.12 | $508.7K | 134,031 |
| Dec 20, 2021↗ | ROSEN TERRY J | Chief Executive Officer | Sell | 5,242 | $40.12 | $210.3K | 215,132 |
RCUS Insiders
Similar Stocks to RCUS
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B